It seems that miR-103 may inhibit vascular endothelial growth factor and neovascularization and promote a decrease in neurological function.19 Our results are consistent with previous reports, and the excessive miR-103 in our study was identified an independent risk factor for poor prognosis in patients with AIS. The gene discussed is VEGFA; the disease is androgen insensitivity syndrome.